AFRM
Same song, lower volume
Citizens JMP took a haircut to its Affirm price target, cutting it from $105 to $85. But don’t confuse that with a true vote of no confidence: the firm kept its market-outperform rating, which is basically Wall Street’s way of saying, “We still like the stock, just not quite as much as before.”
What that means for you
At $85, the new target still implies meaningful upside from the prior close, so this is more of a valuation reset than a thesis breakup. In other words, Affirm is still getting the analyst version of a supportive shoulder squeeze — just with a slightly more realistic budget.
The bigger backdrop
The note lands in a familiar Affirm setup:
- the company recently beat EPS expectations
- revenue growth was still running hot
- but the stock is also carrying the kind of high valuation that makes analysts get nervous when the air gets thin
So yes, the Street still sees upside here. It just doesn’t want to pretend the ride is all smooth sailing.
Big picture
For investors, the key takeaway is that Affirm remains a high-expectations story, and even bullish analysts are starting to taper their optimism. That can matter a lot when a stock is priced like it’s already halfway to perfection.